4 results match your criteria: "Aristotle University of Thessaloniki AHEPA University Hospital[Affiliation]"
miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia.
Oncol Lett
February 2024
Children and Adolescent Hematology-Oncology Unit, 2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki AHEPA University Hospital, Thessaloniki 546 36, Greece.
MicroRNAs (miRNAs/miRs) are promising prognostic biomarkers in pediatric acute lymphoblastic leukemia (ALL). The present study aimed to identify miRNAs that could serve as prognostic biomarkers or as novel therapeutic targets in ALL. The expression levels of 84 miRNAs were assessed in the bone marrow aspirates of 10 pediatric patients with newly diagnosed ALL at diagnosis and on day 33 of induction of the ALL Intercontinental Berlin-Frankfurt-Münster 2009 protocol, and associations with established prognostic factors were evaluated.
View Article and Find Full Text PDFPharmacogenetics and levodopa induced motor complications.
Int J Neurosci
April 2019
a Department of General Biology , Medical School Aristotle University of Thessaloniki, Thessaloniki , Greece.
Aim: L-dopa remains the most effective symptomatic therapy for Parkinson's disease (PD) but unfortunately, its chronic use is often associated with motor complications. This review highlights the importance of pharmacogenetics in an individualised PD therapeutic approach.
Material And Methods: review of the literature was done.